ThinkEquity
http://www.thinkequity.comThinkEquity offers research, investment banking, wealth management, and asset management services for institutional and individual investors.
View Older Stories View More Recent Stories
-
OMNIQ Corp Announces Closing of Private Placement of Unregistered Common Stock and Acquisition of 51% of Dangot Computers
-
VBL Therapeutics (VBLT) Appoints Alison Finger and Michael Rice to its Board of Directors
-
VBL Therapeutics Appoints Alison Finger and Michael Rice to its Board of Directors
-
Kiromic BioPharma, Inc. Announces Closing of Public Offering
-
Context Therapeutics Inc. (CNTX) Files 1.5M Share IPO at $12-$14/sh
-
Twin Vee PowerCats Co. (VEEE) Announce 2M Share Offering at $5-$6/sh
-
cbdMD, Inc. Announces Closing of Underwritten Public Offering of 8.0% Series A Cumulative Convertible Preferred Stock and Full Exercise of Underwriter’s Over-allotment Option for Total Gross Proceed
-
iSpecimen Announces Closing of Over-Allotment Option in Connection with its Initial Public Offering
-
Kiromic BioPharma (KRBP) Prices 8M Share IPO at $5/sh
-
Kiromic BioPharma, Inc. Announces Pricing of Public Offering
-
CardioFocus Appoints Stephan Ogilvie as Chief Financial Officer
-
cbdMD, Inc. Announces Pricing of $14.3 Million 8.0% Series A Cumulative Convertible Preferred Stock Offering
-
Second Sight Medical Products Announces Closing of Public Offering
-
Second Sight Medical (EYES) Prices 10M Share Offering at $5/sh
-
Second Sight Medical Products Announces Pricing of Public Offering
-
Second Sight Medical (EYES) Announces Proposed Offering, Size not Disclosed
-
Second Sight Medical Products Announces Proposed Public Offering of Common Stock
-
FAT Brands Inc. Announces Closing of Public Offering of Series B Cumulative Preferred Stock and Full Exercise of Underwriter’s Overallotment Option
-
FAT Brands Inc. Announces Closing of Public Offering of Series B Cumulative Preferred Stock and Full Exercise of Underwriter’s Overallotment Option
-
iSpecimen Announces Closing of Initial Public Offering
-
Inhibikase Therapeutics Announces Closing of Follow-On Offering of Common Stock
-
FAT Brands Inc. Announces Pricing of Public Offering of Series B Cumulative Preferred Stock
-
FAT Brands Inc. Announces Pricing of Public Offering of Series B Cumulative Preferred Stock
-
iSpecimen (ISPC) IPO Opens 22% Lower
-
iSpecimen (ISPC) IPO Prices at $8
-
iSpecimen Announces Pricing of Initial Public Offering
-
Inhibikase Therapeutics (IKT) Prices 15M Shares at $3
-
Inhibikase Therapeutics Prices Follow-On Public Offering of Common Stock
-
Harbor Custom Development, Inc. Announces Closing of $30.0 Million Public Offering of Convertible Preferred Shares & Warrants
-
Harbor Custom Development, Inc. Announces Closing of $30.0 Million Public Offering of Convertible Preferred Shares & Warrants
-
Cardiff Oncology Announces the Appointment of Two New Independent Members to its Board of Directors
-
BK Technologies Corporation Announces Closing of Public Offering, Including Full Exercise of Underwriters' Over-allotment Option
-
Harbor Custom Development (HCDI) Announces Pricing of $30 Million Public Offering of Convertible Preferred Shares & Warrants
-
Harbor Custom Development, Inc. Announces Pricing of $30 Million Public Offering of Convertible Preferred Shares & Warrants
-
Harbor Custom Development, Inc. Announces Pricing of $30 Million Public Offering of Convertible Preferred Shares & Warrants
-
Aura Biosciences Appoints Sapna Srivastava, Ph.D., to its Board of Directors
-
BriaCell Therapeutics Corp. Announces Closing of US$27.2 Million Private Placement
-
BK Technologies Corporation Announces Pricing of $11 Million Public Offering
-
BK Technologies Corporation Announces Proposed Public Offering of Common Stock
-
1847 Goedeker Inc. (GOED) Announces Closing of $205 Million Public Offering, $70 Million Debt Financing and Acquisition of Appliances Connection
-
1847 Goedeker Announces Closing of $205 Million Public Offering, $70 Million Debt Financing and Acquisition of Appliances Connection
-
1847 Goedeker Announces Pricing of $205 Million Public Offering
-
Annovis Bio, Inc. Announces Closing of $50 Million Public Offering
-
Comscore Adds Veteran Media and Entertainment Analyst John Tinker as Vice President of Investor Relations
-
Annovis Bio, Inc. Announces Pricing of Public Offering
-
Annovis Bio, Inc. Announces Proposed Public Offering of Common Stock
-
FG Financial Group, Inc. Announces Closing of Public Offering, Including Full Exercise of Underwriters’ Over-allotment Option
-
FG Financial Group, Inc. Announces Pricing of Public Offering
-
SAVE FOODS, INC. ANNOUNCES CLOSING OF $12 MILLION PUBLIC OFFERING AND NASDAQ LISTING
-
SAVE FOODS, INC. ANNOUNCES CLOSING OF $12 MILLION PUBLIC OFFERING AND NASDAQ LISTING

